Bristol Myers Squibb (BMY) Return on Sales (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales climbed to 0.0% in Q1 2026 per BMY's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q1 2026 and bottomed at 0.01% in Q1 2024.
• The 5-year median for Return on Sales is 0.0% (2022), against an average of 0.0%.
• The widest annual swing landed in 2024, when Return on Sales fell 1 bps; it then grew 1 bps in 2025.
• Tracing BMY's Return on Sales over 5 years: stood at 0.0% in 2022, then declined by 14 bps to 0.0% in 2023, then sank by 96 bps to 0.0% in 2024, then soared by 1311 bps to 0.0% in 2025, then jumped by 168 bps to 0.0% in 2026.
• Per Business Quant, the three latest BMY Return on Sales figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison